Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
Liver stiffness measurement (LSM) using transient elastography (Fibroscan®) can identify individuals with potential underlying liver disease. We evaluated the prevalence of abnormal LSM values as assessed using LSM and its predictors in HIV-infected asymptomatic patients receiving combined antiretro...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3536776?pdf=render |
_version_ | 1818947866500005888 |
---|---|
author | Sang Hoon Han Seung Up Kim Chang Oh Kim Su Jin Jeong Jun Yong Park Jun Yong Choi Do Young Kim Sang Hoon Ahn Young Goo Song Kwang-Hyub Han June Myung Kim |
author_facet | Sang Hoon Han Seung Up Kim Chang Oh Kim Su Jin Jeong Jun Yong Park Jun Yong Choi Do Young Kim Sang Hoon Ahn Young Goo Song Kwang-Hyub Han June Myung Kim |
author_sort | Sang Hoon Han |
collection | DOAJ |
description | Liver stiffness measurement (LSM) using transient elastography (Fibroscan®) can identify individuals with potential underlying liver disease. We evaluated the prevalence of abnormal LSM values as assessed using LSM and its predictors in HIV-infected asymptomatic patients receiving combined antiretroviral treatment (cART) without HBV/HCV coinfection.We prospectively recruited 93 patients who had consistently been undergoing cART for more than 12 months at Severance Hospital in Seoul, Republic of Korea, from June to December 2010. LSM values >5.3 kPa were defined as abnormal.Thirty-nine (41.9%) had abnormal LSM values. On multivariate correlation analysis, the cumulative duration of boosted and unboosted protease inhibitors (PIs) were the independent factors which showed a negative and positive correlation to LSM values, respectively (β = -0.234, P = 0.023 and β = 0.430, P<0.001). In multivariate logistic regression analysis, the cumulative exposure duration of boosted-PIs and γ-glutamyltranspeptidase levels were selected as the independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively (odds ratio [OR], 0.941; 95% confidence interval [CI], 0.889-0.997; P = 0.039 and OR, 1.032; 95% CI, 1.004-1.060; P = 0.023).The high percentage of HIV-infected asymptomatic patients receiving cART without HBV/HCV coinfection had abnormal LSM values. The cumulative exposure duration of boosted-PIs and γ-GT level were independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively. |
first_indexed | 2024-12-20T08:37:43Z |
format | Article |
id | doaj.art-1f8bcafb84bc42c2b62f380ce533b45f |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-20T08:37:43Z |
publishDate | 2013-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-1f8bcafb84bc42c2b62f380ce533b45f2022-12-21T19:46:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5272010.1371/journal.pone.0052720Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.Sang Hoon HanSeung Up KimChang Oh KimSu Jin JeongJun Yong ParkJun Yong ChoiDo Young KimSang Hoon AhnYoung Goo SongKwang-Hyub HanJune Myung KimLiver stiffness measurement (LSM) using transient elastography (Fibroscan®) can identify individuals with potential underlying liver disease. We evaluated the prevalence of abnormal LSM values as assessed using LSM and its predictors in HIV-infected asymptomatic patients receiving combined antiretroviral treatment (cART) without HBV/HCV coinfection.We prospectively recruited 93 patients who had consistently been undergoing cART for more than 12 months at Severance Hospital in Seoul, Republic of Korea, from June to December 2010. LSM values >5.3 kPa were defined as abnormal.Thirty-nine (41.9%) had abnormal LSM values. On multivariate correlation analysis, the cumulative duration of boosted and unboosted protease inhibitors (PIs) were the independent factors which showed a negative and positive correlation to LSM values, respectively (β = -0.234, P = 0.023 and β = 0.430, P<0.001). In multivariate logistic regression analysis, the cumulative exposure duration of boosted-PIs and γ-glutamyltranspeptidase levels were selected as the independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively (odds ratio [OR], 0.941; 95% confidence interval [CI], 0.889-0.997; P = 0.039 and OR, 1.032; 95% CI, 1.004-1.060; P = 0.023).The high percentage of HIV-infected asymptomatic patients receiving cART without HBV/HCV coinfection had abnormal LSM values. The cumulative exposure duration of boosted-PIs and γ-GT level were independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively.http://europepmc.org/articles/PMC3536776?pdf=render |
spellingShingle | Sang Hoon Han Seung Up Kim Chang Oh Kim Su Jin Jeong Jun Yong Park Jun Yong Choi Do Young Kim Sang Hoon Ahn Young Goo Song Kwang-Hyub Han June Myung Kim Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. PLoS ONE |
title | Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. |
title_full | Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. |
title_fullStr | Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. |
title_full_unstemmed | Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. |
title_short | Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. |
title_sort | abnormal liver stiffness assessed using transient elastography fibroscan r in hiv infected patients without hbv hcv coinfection receiving combined antiretroviral treatment |
url | http://europepmc.org/articles/PMC3536776?pdf=render |
work_keys_str_mv | AT sanghoonhan abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT seungupkim abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT changohkim abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT sujinjeong abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT junyongpark abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT junyongchoi abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT doyoungkim abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT sanghoonahn abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT younggoosong abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT kwanghyubhan abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment AT junemyungkim abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment |